(Q42798609)

7 November 2017

0 references

Posaconazole treatment for Apophysomyces elegans rhino-orbital zygomycosis following trauma for a male with well-controlled diabetes (English)

1 reference

7 November 2017

1 reference

T D Ferguson

1

1 reference

7 November 2017

S D Schniederjan

2

1 reference

7 November 2017

J Dionne-Odom

3

1 reference

7 November 2017

M E Brandt

4

1 reference

7 November 2017

M G Rinaldi

5

1 reference

7 November 2017

F S Nolte

6

1 reference

7 November 2017

A Langston

7

1 reference

7 November 2017

S M Zimmer

8

1 reference

7 November 2017

language of work or name

English

0 references

publication date

7 March 2007

1 reference

Journal of Clinical Microbiology

7 November 2017

1 reference

7 November 2017

45

1 reference

7 November 2017

5

1 reference

7 November 2017

1648-1651

1 reference

Antifungal prophylaxis for invasive mycoses in high risk patients

7 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1865874

Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1865874

Zygomycosis: the re-emerging fungal infection

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1865874

Rhino-orbitocerebral mucormycosis caused by Apophysomyces elegans

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1865874

Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1865874

Posaconazole as salvage therapy for zygomycosis

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1865874

Posaconazole: a broad-spectrum triazole antifungal

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1865874

Activity of posaconazole in the treatment of central nervous system fungal infections

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1865874

Epidemiology and outcome of zygomycosis: a review of 929 reported cases

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1865874

Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1865874

Testing conditions for determination of minimum fungicidal concentrations of new and established antifungal agents for Aspergillus spp.: NCCLS collaborative study

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1865874

Rhino-orbitocerebral mucormycosis attributable to Apophysomyces elegans in an immunocompetent individual: case report and review of the literature

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1865874

Invasive infection due to Apophysomyces elegans in immunocompetent hosts

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1865874

Simple method of inducing sporulation by Apophysomyces elegans and Saksenaea vasiformis.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1865874

In vitro susceptibility of 15 strains of zygomycetes to nine antifungal agents as determined by the NCCLS M38-A microdilution method

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1865874

Apophysomyces elegans as an agent of zygomycosis in a patient following trauma

16 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17344359

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/JCM.00014-07

1 reference

7 November 2017

1 reference

7 November 2017

PubMed publication ID

17344359

1 reference